发明名称 2-(3, 5-BIS- TRIFLUOROMETHYL -PHENYL)-N -[6-(1, 1-DIOXO-1?6 -THIOMORPHOLIN -4-YL) -4-(2-METHYL OR 4-FLUORO -2-METHYL SUBSTITUTED) PHENYL-PYRIDIN -3-YL]-N -METHYL -ISOBUTYRAMIDE.
摘要 <p>The invention relates to the compounds 2-(3, 5-bis -trifluoromethyl-phenyl) N-[6-(1, 1-dioxo-1lambd6 -thiomorpholin-4 -yl)-4-o-tolyl -pyridin-3 -yl]-N -methyl-isobutyramide and 2-(3, -bis-trifluoromethyl -phenyl)-N -[6-(1, 1-dioxo-1lambd6 -thiomorpholin- 4-yl)-4-(4- fluoro-2-methyl- phenyl)-pyridin -3-yl] -N-methyl-isobutyramide, which may be used for the treatment of migraine, rheumatoid arthritis, asthma, bronchial hyperreactivity, inflammatory bowel disease or for the treatment of disorders including Parkinson's disease, anxiety, depression, pain, headache, Alzheimer's disease, multiple sclerosis,oedema, allergic rhinitis, Crohn's disease, ocular injury, ocular inflammatory diseases, psychosis, motion sickness, induced vomiting, emesis, urinary incontinence, psychoimmunologic or psychosomatic disorders, cancer, withdrawel symptoms of addictive drugs from opiates or nicotine, traumatic brain injury or benign prostatic hyperplasia.</p>
申请公布号 MXPA04000917(A) 申请公布日期 2004.04.02
申请号 MX2004PA00917 申请日期 2002.07.26
申请人 F. HOFFMANN - LA ROCHE AG 发明人 PATRICK SCHNIDER.
分类号 A61K31/541;A61P1/00;A61P1/08;A61P11/00;A61P11/02;A61P11/06;A61P13/02;A61P13/08;A61P25/00;A61P25/04;A61P25/06;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P27/02;A61P29/00;A61P35/00;A61P37/08;A61P43/00;C07D213/75 主分类号 A61K31/541
代理机构 代理人
主权项
地址